Background-Pain triggers a homeostatic alarm reaction to injury. It remains unknown, however, whether nociceptive signaling activated by ischemia is relevant for progenitor cells (PC) release from bone marrow. To this end, we investigated the role of the neuropeptide substance P (SP) and cognate neurokinin 1 (NK1) nociceptor in PC activation and angiogenesis during ischemia in mice and in human subjects. Methods and Results-The mouse bone marrow contains sensory fibers and PC that express SP. Moreover, SP-induced migration provides enrichment for PC that express NK1 and promote reparative angiogenesis after transplantation in a mouse model of limb ischemia. Acute myocardial infarction and limb ischemia increase SP levels in peripheral blood, decrease SP levels in bone marrow, and stimulate the mobilization of NK1-expressing PC, with these effects being abrogated by systemic administration of the opioid receptor agonist morphine. Moreover, bone marrow reconstitution with NK1-knockout cells results in depressed PC mobilization, delayed blood flow recovery, and reduced neovascularization after ischemia. We next asked whether SP is instrumental to PC mobilization and homing in patients with ischemia. Human PC express NK1, and SP-induced migration provides enrichment for proangiogenic PC. Patients with acute myocardial infarction show high circulating levels of SP and NK1-positive cells that coexpress PC antigens, such as CD34, KDR, and CXCR4. Moreover, NK1-expressing PC are abundant in infarcted hearts but not in hearts that developed an infarct after transplantation.
ecting to distinct brain stem levels, thus contributing to pain perception and pain-induced reactions. In addition, neuropeptides released from peripheral terminals of sensory neurons induce neurogenic inflammation, angiogenesis, and wound healing. 2, 7 Neuropeptides can also enter the systemic circulation, reaching distant organs where they regulate additional cellular responses. SP mediates its effects by preferentially binding and activating the tachykinin receptor neurokinin 1 (NK1), whereas CGRP acts on the calcitonin receptor-like receptor (CRLR), which is associated with and functionally regulated by the receptor activity-modifying protein 1 (RAMP-1). 8 Growing evidence indicates the implication of bone marrow sympathetic fibers in the regulation of PC proliferation and mobilization. 9 -11 However, the role of nociceptors has not been investigated thoroughly. 12 A recent study showed that induction of corneal ulcers increases peripheral blood levels of SP, which in turn contributes to wound healing through the mobilization of mesenchymal stem cells from the bone marrow. 2 This seminal work suggests that noxious stimuli could activate cell mobilization through local nerves and neuropeptides from the circulation.
The present study investigates whether SP-based signaling modulates the mobilization of proangiogenic PC, thereby contributing to postischemic tissue healing. Our results newly show that ischemia induces reactive cellular responses in both animals and humans through the activation of SP release from peripheral nociceptors and modulation of SP content in bone marrow. This signaling mechanism is important for proper revascularization in animal models of ischemia.
Methods
Expanded methods are provided in the online-only Data Supplement.
Animal Studies
Seven-to 8-week old male CD1 and C57BL/6 mice (both from Harlan) and transgenic mice expressing an "enhanced" green fluorescent protein cDNA under the control of a chicken ␤-actin promoter and cytomegalovirus enhancer (Jackson Laboratory) were used. Furthermore, bone marrow reconstitution experiments were performed with the use of NK1-knockout (NK1-KO) or wildtype littermate mice as donors and sublethally irradiated wild-type mice as recipients. NK1-KO mice were generated by inserting a cassette containing an internal ribosome entry site and the LacZ coding sequence together with a neomycin resistance gene in exon 1 of the NK1 gene. 13 All experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) and with approval of the British Home Office and the University of Bristol.
Myocardial Infarction Model
Myocardial infarction was induced by occlusion of the left anterior descending coronary artery. 14 Twenty-four hours later, peripheral blood and bone marrow were collected for assessment of neuropeptide levels, immunohistochemistry, and flow cytometry analysis of cell antigenic profiles.
Limb Ischemia Model
Operative unilateral limb ischemia was induced as described previously. 15 Mice were then allocated to specific experimental protocols (see below). Blood flow recovery was measured by laser Doppler flowmetry (Moor Instruments, UK) immediately after induction of ischemia and 3, 7, 14, and 21 days thereafter. Then mice were euthanized, and the adductor muscles were collected for assessment of capillary and arteriole density.
Effect of Morphine on SP Release and PC Mobilization After Limb Ischemia
CD1 mice received morphine (20 mg/kg IP) 16 10 minutes before and 12 and 24 hours after induction of ischemia, whereas controls received vehicle. Peripheral blood and bone marrow were collected immediately before (time 0) and 1, 3, 12, 24, and 48 hours after induction of ischemia (nϭ3 per time point) for measurement of SP levels (EIA, Cayman Chemical) and flow cytometry assessment of NK1-expressing PC.
Effect of Bone Marrow Reconstitution With NK1-KO Cells on PC Mobilization and Reparative Angiogenesis
Wild-type mice were sublethally irradiated and then randomly assigned to receive 1ϫ10 6 marrow cells from NK1-KO or wild-type mice through the tail vein (nϭ12 in each group). Eight weeks later, chimerism was verified on peripheral blood cells of recipient mice by assessing the expression of NK1 by polymerase chain reaction and LacZ transgene by ␤-galactosidase assay (Calbiochem, UK). Then mice were submitted to limb ischemia, and perfusion recovery was monitored until 21 days after ischemia. Peripheral blood samples were collected from the tail vein at day 3 to assess PC mobilization. At euthanasia, the adductor muscles were harvested after perfusion fixation for analysis of capillaries and arterioles. Cryosections of femurs were stained with a ␤-galactosidase antibody (AbD Serotec, UK) to confirm chimerism.
Effect of Exogenous SP on PC Mobilization
To demonstrate the direct effect of neuropeptide on mobilization, CD1 mice were injected with SP (5 nmol/L per kilogram IV; Bachem, UK), 13 followed by collection of peripheral blood at 1, 3, 12, 24, and 48 hours (nϭ3 per time point) for measurement of SP and PC levels.
Transplantation of NK1-Enriched Cells in a Mouse Limb Ischemia Model
We next investigated whether the fraction of bone marrow cells that is functionally responsive to neuropeptides possesses proangiogenic activity in vivo. To this aim, bone marrow cells of enhanced green fluorescent protein-transgenic mice were submitted to a migration assay with the use of SP or CGRP as chemoattractant. The cells migrating to the lower chamber of the migration system (ie, SP-or CGRP-migrated cells [SP mig and CGRP mig cells, respectively]) or the cells migrating spontaneously in the presence of vehicle were harvested and, within 3 hours, transplanted into 3 different sites of the left adductor muscle of C57Bl/6 mice at the occasion of limb ischemia induction (1ϫ10 5 cells per 30 L phosphate-buffered saline per mouse). Control animals were injected with vehicle. Blood flow recovery was monitored until 21 days. At euthanasia, the adductor muscles were collected for analysis of neovascularization.
Immunostaining Procedures

Immunohistochemistry
Bones were fixed with 4% paraformaldehyde for 24 hours at 4°C and decalcified. Sections of 15-m thickness were mounted on poly-Llysine-coated slides and processed for immunostaining. 17 The immunosignal was amplified with the use of a tyramide signal amplification kit according to the manufacturer's instructions (PerkinElmer).
The capillary and arteriolar densities of ischemic limb muscles were assessed with the use of isolectin B4 (Invitrogen) and ␣-smooth muscle actin (Sigma) staining as reported. 15 Counts from 30 microscopic fields were averaged and expressed as the number of capillaries and arterioles per square-millimeter section.
Immunocytochemistry
Bone marrow cells were depleted from lineage-positive cells, and a cytospin from single-cell suspension was processed for immunostaining. Slides were mounted in Vectashield mounting medium containing 4Ј,6-diamidino-2-phenylindole (DAPI) and observed with a confocal microscope with a ϫ63 objective.
Cells and Cell Culture
Mouse Bone Marrow Cell Isolation
Bone marrow cells were depleted of mature hematopoietic cells by magnetic cell sorting with the use of a lineage cell depletion kit and a cocktail of lineage marker antibodies (MACS, Miltenyi Biotec) and then processed for immunocytochemistry or in vitro functional assays. 18
Primary Culture of Mouse Sensory Neurons
Dorsal root ganglia (DRG) from mouse thoracic and lumbar spinal cords were cultured for 48 hours in Dulbecco's modified Eagle's medium containing 5% fetal bovine serum and 5% horse serum. 100 U/mL penicillin, 0.1 mg/mL streptomycin, and 2 mmol/L glutamine. 19 DRG were then cultured overnight in 0.25% fetal bovine serum and 0.25% horse serum and next DRG and DRG conditioned media were used in migration assays.
In Vitro Assays
Migration
Cell migration was assessed with the use of transwell cell culture inserts with 3-to 5-m pore size filters as described. 20 Briefly, freshly isolated cells were plated in the upper compartment, and the test compound, DRG or conditioned medium was placed in the lower compartment. After 16 hours, cells from the upper (nonmigrated cells) and lower compartments (migrated cells) were collected and processed for flow cytometry analysis with the use of AccuCheck counting beads (Invitrogen) for absolute and reproducible quantification of cell numbers. Migration-induced enrichment of antigenically defined populations was expressed as the ratio of migrated to nonmigrated cells, followed by normalization to control (vehicle). This double normalization allows for direct control of changes in the antigenic profile that may have occurred during the migration assay. Furthermore, we know from pilot experiments that the attractant per se does not alter the cell antigenic characteristics. In selected experiments, cells were pretreated with CGRP and SP receptor antagonists for 30 minutes.
In Vitro Angiogenesis Assay
Migrated and nonmigrated cell fractions were cocultured on Matrigel with human umbilical vein endothelial cells for 16 hours at 37°C. Network formation was quantified by counting the number of branches per view field with the use of Image Pro-Plus software (Media Cybernetics). Each condition was performed with 6 biological replicates, and the assay was repeated 3 times. Counts of migrated cells were normalized by counts of respective nonmigrated cells. 15
Flow Cytometry
Cells were stained with primary and secondary antibodies and then analyzed with the use of a FACS Canto II equipped with FACS Diva software (BD Biosciences). 20 In the text and figures, we will refer to cells expressing different markers by stating the cluster of differentiation marker (eg, CD117/c-Kit) followed by positive or negative in superscript format (eg, c-Kit ϩ ).
Western Blot Analysis
Protein extracts and immunoblot analyses were performed as described. 21 Briefly, lineage-negative cells were starved for 3 hours in low serum medium and then treated with SP (100 nmol/L, 15 minutes in RPMI medium). Protein extracts from cell lysates were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and processed for Western blotting with the use of phospho-Akt (Ser473) and total Akt antibodies (Cell Signaling Technology) and a horseradish peroxidase-conjugated anti-rabbit secondary antibody (Sigma).
Reagents
SP, CGRP, and ␣-CGRP 8 -37 , a CGRP receptor antagonist, were from Bachem. The NK1 antagonist RP67580 was from Tocris Bioscience. LY294002, a phosphoinositide-3 kinase antagonist, was from Calbiochem. Lineage markers and primary and secondary antibodies used for immunostaining are reported in Table I in the online-only Data Supplement.
Human Studies
Experiments on human samples complied with the principles stated in the Declaration of Helsinki and were covered by institutional ethical approval. Subjects gave written informed consent to sample collection.
Peripheral blood was obtained for assessment of neuropeptide receptor-expressing cells from patients with acute myocardial infarction and age-matched controls with similar risk factors but no evidence of coronary artery disease who participated in an observational clinical trial on the prognostic value of circulating PC at IRCCS MultiMedica, Milan, Italy (http://www.clinicaltrials.gov; identifier: NCT01271309) ( Table II in the online-only Data Supplement). Moreover, migration assays followed by flow cytometry characterization of migrated cells were performed on peripheral blood mononuclear cells from 6 healthy subjects (average age, 30 years) and bone marrow mononuclear cells from 4 patients participating in the Bristol Heart Institute cell therapy trial TransACT1 (http:// www.controlled-trials.com; identifier: ISRCTN65630838/Trans-ACT) ( Table III in the online-only Data Supplement) .
Finally, human heart explants were collected from patients (nϭ9) who underwent cardiac transplantation 4 to 13 days after acute myocardial infarction at the University Hospital of Udine, Udine, Italy ( Table IV in the online-only Data Supplement). Three of these patients had received a second transplantation for an infarct of the graft, which led in 2 cases to cardiogenic shock. Samples from infarcted area, border, and distant myocardium were obtained for immunohistochemistry of SP, NK1, CD34, and CD45 on 5-m-thick paraffin-embedded sections. Control specimens from comparable areas were sampled from explanted hearts that were judged not suitable for cardiac transplantation (nϭ5).
Statistical Analysis
Results are presented as meanϮSEM. If data failed to pass normality and equal variance tests, a nonparametric analysis was applied, and results are expressed as median with 5 to 95 percentile distribution. Multiple groups were compared by parametric ANOVA, followed by Bonferroni t test, or nonparametric ANOVA on ranks, followed by Tukey pairwise comparison or Dunnett test for multiple comparisons against a single control group. Analysis of the effect of bone marrow transplantation on postischemic blood flow recovery was performed with repeated-measures ANOVA followed by Bonferroni multiple comparison. Comparison of 2 groups was performed by paired or unpaired Student t test or Mann-Whitney rank sum test. PϽ0.05 was considered significant. Stated n values represent biological replicates.
Results
Sensory Neuropeptidergic Neurons Are Present in Mouse Bone Marrow
Using the panneuronal marker Protein Gene Product 9.5 (PGP 9.5), we showed the presence of nerve fibers in the periosteum and endosteum and also in marrow perivascular areas of femur epiphysis ( Figure I in the online-only Data Supplement). We also found that a subset of these fibers in trabecular bone and marrow is positive for nociceptor markers, such as SP (Figure 1) , CGRP, and transient receptor potential cation channel subfamily V member 1 (TRPV1) ( Figure I in the online-only Data Supplement).
We then analyzed the expression of SP and CGRP receptors on cytospin preparations of mouse bone marrow cells. We found that lineage-negative (Lin Ϫ ) cells express the SP receptor NK1 at the plasma membrane and also within cytoplasmic vesicles (Figure 2A) . Similarly, we found that bone marrow cells express the CGRP receptors RAMP-1 and CRLR (Figure 2A through 2C). The immunoreactive signal was not detected when primary antibodies were omitted (Figure 2A and 2D). We further confirmed and quantified the percentage of cells expressing SP and CGRP receptors by flow cytometry. We found that freshly isolated bone marrow cells abundantly express NK1 (86Ϯ1%), RAMP-1 (50Ϯ2%), and CRLR (77Ϯ2%) ( Figure 2B through 2D). Moreover, neuropeptide receptor-positive cells coexpress markers for hematopoietic PC. Of the NK1 ϩ cells ( Figure 2B ), 40Ϯ2% were Lin Ϫ , 28Ϯ2% expressed c-Kit (the receptor for stem cell factor), and 8Ϯ1% expressed Sca-1 (typical markers for hematopoietic PC). Of the RAMP-1 ϩ ( Figure 2C ) and CRLR ϩ cells ( Figure 2D ), 45Ϯ2% and 68Ϯ2% were Lin Ϫ , 22Ϯ1% and 29Ϯ1% expressed c-Kit, and 6Ϯ1% and 5Ϯ1% expressed Sca-1, respectively. Moreover, 15Ϯ3% of the NK1 ϩ , 15Ϯ2% of the RAMP-1 ϩ , and 52Ϯ9% of CRLR ϩ cells also expressed CXCR4 (data not shown). Within the Lin Ϫ Sca-1 ϩ c-Kit ϩ PC population, 98Ϯ1% expressed NK1, 89Ϯ1% RAMP-1, and 91Ϯ3% CRLR. Nonhematopoietic cells identified as c-Kit ϩ CD45 Ϫ cells also expressed NK1 (62Ϯ4%), RAMP-1 (65Ϯ7%), and CRLR (73Ϯ7%) (data not shown). Thus, neuropeptides and their receptors are abundantly expressed in mouse bone marrow cells.
SP and CGRP Exert Chemoattractant Activity on Bone Marrow PC
We next assessed whether neuropeptides regulate bone marrow cells motility. Using the transwell migration assay, we found that SP and CGRP (100 -1000 nmol/L) exert a chemoattractant action on Lin Ϫ cells ( Figure 3A) . These effects were reduced in cells treated 30 minutes in advance with the NK1 antagonist RP675880 (75% reduction of SP response; nϭ3; Pϭ0.005) or the CGRP antagonist CGRP 8 -37 (76% reduction of CGRP 100 nmol/L response; nϭ4; Pϭ0.001). We also found that stimulation of Lin Ϫ cells with SP for 15 minutes increases the phosphorylation of Akt, and this is prevented by the PI3K antagonist LY294002 ( Figure 3B , top and left). Moreover, PI3K inhibition prevented PC migration induced by SP ( Figure 3B , right). SP and CGRP (both at 100 nmol/L) increased cAMP production in Lin Ϫ PC (SP, 1.5Ϯ0.3-fold; CGRP, 1.8Ϯ0.5-fold; nϭ3).
We next investigated whether neuropeptides released by nerve terminals exert a retaining action on bone marrow cells. To this aim, we used primary cultures of sensory neurons isolated from mouse DRG or conditioned medium in a migration assay on bone marrow cells. DRG and DRG conditioned medium induced the migration of bone marrow cells and the enrichment of c-Kit ϩ Sca-1 ϩ PC within the migrated fraction ( Figure 3C and 3D). The chemoattractant effect induced by DRG was reduced by NK1 and CGRP antagonists ( Figure 3E ).
Ischemia Increases Peripheral Blood Levels of SP and Induces the Mobilization of NK1-Expressing Cells
Next we evaluated the mobilization of NK1-and CGRPexpressing cells in relation to changes of SP and CGRP levels in mouse models of acute myocardial infarction and limb ischemia. Circulating levels of SP were increased by 5-fold 24 hours after myocardial infarction compared with controls (236Ϯ80 versus 48Ϯ19 pg/mL, respectively; nϭ6 per group; PϽ0.05), whereas no difference between groups was detected in bone marrow levels of SP (Pϭ0.35).
Analysis of distinct cell populations showed that myocardial infarction increases the abundance of granulocytes in peripheral blood while reducing them in bone marrow ( Figure  II in the online-only Data Supplement). Similarly, myocardial infarction induced a 1.8-fold increase in CD45 ϩ c-Kit ϩ NK1 ϩ granulocytes in peripheral blood (12 657Ϯ1532 versus 6819Ϯ827 cells per 100 L in controls; nϭ6 per group; PϽ0.01) and a reduction of their relative abundance in bone marrow (41.0Ϯ0.6% versus 52.0Ϯ1.0% in controls; PϽ0.01). The abundance of total and CD45 ϩ c-Kit ϩ NK1 ϩ lymphocytes/ monocytes was not altered in both peripheral blood and bone marrow (data not shown). Moreover, myocardial infarction did not induce any change in circulating CGRP and in the abundance of cell populations expressing CGRP receptors (data not shown).
Limb ischemia caused opposite changes in the levels of SP in bone marrow ( Figure 4A ) and peripheral blood ( Figure  4B) , resulting in the modification of SP gradient between the 2 compartments. This was associated with an increased abundance of Sca-1 ϩ NK1 ϩ ( Figure 4F ) and Sca-1 ϩ c-Kit ϩ NK1 ϩ granulocytes (3-fold; data not shown) in peripheral blood from 24 hours after ischemia, whereas the change in c-Kit ϩ NK1 ϩ granulocytes was not significant ( Figure 4E ).
Nociceptive signaling is modulated by opioid receptors at the level of the central nervous system and primary afferent neurons. We next investigated whether opioid-induced analgesia interferes with the release of SP and the mobilization of nociceptor-expressing cells in mice with limb ischemia. Morphine inhibited the increase of SP in peripheral blood ( Figure 4D ) and blunted the decrease of SP in bone marrow ( Figure 4C) , thus nullifying the SP gradient between the 2 compartments. Moreover, we found that morphine remarkably attenuated the mobilization of NK1-expressing PC after ischemia ( Figure 4G and 4H) . In addition, we showed that systemic injection of SP per se, in the absence of ischemia, temporarily increases SP in peripheral blood and concomitantly induces the mobilization of Sca-1 ϩ c-Kit ϩ NK1 ϩ cells ( Figure III in the online-only Data Supplement).
Role of NK1-Expressing Bone Marrow Cells in Postischemic Healing
To investigate the relevance of NK1-expressing cells in the reparative process after ischemia, sublethally irradiated mice were randomly assigned to bone marrow replacement with cells from NK1-KO or wild-type mice (nϭ12 in each group). Eight weeks later, mice were subjected to unilateral limb ischemia ( Figure 5A ). Mice transplanted with NK1-KO cells showed reduced peripheral blood levels of c-Kit ϩ granulocytes compared with controls transplanted with wild-type cells ( Figure 5B ). Moreover, repeatedmeasures ANOVA showed that blood flow recovery is delayed in the former group ( Figure 5C ). In agreement with this finding, NK1-KO cell recipients showed reduced reparative neovascularization at the capillary and arteriolar levels compared with mice replaced with wild-type bone marrow cells ( Figure 5D ).
Neuropeptide-Induced Migration Enriches PC Able to Promote Reperfusion of Ischemic Limbs
To determine whether cells responsive to neuropeptideinduced chemoattraction are endowed with reparative activity, we transplanted mouse bone marrow cells that migrate toward SP (SP mig cells) or CGRP (CGRP mig cells) into the adductor muscle of mice with unilateral limb ischemia. Cells migrating toward vehicle (Veh mig cells) were used as controls. Flow cytometry analysis of cells, before transplantation, indicated that migration itself provides enrichment for c-Kit ϩ PC, and this effect is enhanced when migration is stimulated by SP and CGRP ( Figure 6A ). Using laser Doppler flowmetry, we found that mice transplanted with SP mig and CGRP mig cells have improved blood flow recovery at 3 weeks after ischemia compared with mice injected with vehicle (no cells) or Veh mig cells ( Figure 6B and 6C ). Analysis of ischemic adductor vascularization showed an effect of cell transplantation on arteriolar density in SP mig and Veh mig cell groups compared with vehicle ( Figure 6D ). 
Amadesi et al Nociception Triggers Stem Cell Mobilization
Human PC Express Neuropeptide Receptors
Circulating CD34 ϩ PC from healthy subjects express neuropeptide receptors ( Figure 7A ) (gating strategies reported in Figure IV in the online-only Data Supplement) and migrate toward SP and CGRP (Ϸ1.6-and 1.2-fold increase compared with vehicle), and this migratory activity is inhibited by NK1 and CGRP antagonism ( Figure 7B ). Moreover, neuropeptideinduced migration provides enrichment for CD34 ϩ CXCR4 ϩ ( Figure 7C ) and CD34 ϩ KDR ϩ PC ( Figure 7D ) coexpressing NK1 and RAMP-1. In particular, NK1 expression is increased in the CD34 ϩ CXCR4 ϩ and CD34 ϩ KDR ϩ cell subfractions migrating toward SP. Likewise, CGRP induces a distinct enrichment of RAMP-1 ϩ cells but does not enrich cells expressing CRLR. Interestingly, CD34 ϩ KDR ϩ NK1 ϩ and CD34 ϩ KDR ϩ RAMP-1 ϩ PC are attracted by both agonists. Furthermore, PC selected by SP-and CGRP-induced migration are able to enhance human umbilical vein endothelial cell branch formation on Matrigel compared with nonmigrated cells, thus indicating the in vitro proangiogenic activity of cells that are functionally responsive to neuropeptides ( Figure 7E ). We next asked whether human bone marrow cells also express neuropeptide receptors. Flow cytometry analysis of freshly collected bone marrow from patients with chronic myocardial ischemia showed the abundance of neuropeptide receptors on CD34 ϩ cells, which are 75Ϯ15% NK1 ϩ , 70Ϯ20% RAMP-1 ϩ , and 75Ϯ20% CRLR ϩ . Moreover, of CXCR4 ϩ cells, 73Ϯ6% are NK1 ϩ , 55Ϯ15% RAMP-1 ϩ , and 56Ϯ22% CRLR ϩ (nϭ4). We also found that SP and CGRP induce a migratory effect on human bone marrow mononuclear cells (1.3-and 1.2-fold increase, respectively, versus vehicle) ( Figure V 
SP Modulates PC Mobilization and Homing in Patients With Acute Myocardial Infarction
Finally, we investigated the implication of the SP signaling pathway in PC mobilization and homing in patients with myocardial infarction. We found higher circulating SP levels in myocardial infarction patients (142Ϯ32 pg/mL; nϭ23) compared with healthy controls (46Ϯ6 pg/mL; nϭ19; Pϭ0.001) ( Figure 8A) , whereas CGRP did not differ between the 2 groups (30.5Ϯ10.9 versus 14.7Ϯ2.0 pg/mL; Pϭ0.11). This was associated with a remarkable increase in the relative abundance of cells expressing NK1 and RAMP-1 within the CD34 ϩ CXCR4 ϩ and CD34 ϩ KDR ϩ PC fractions ( Figure 8B and 8C) as well as in the proportion of NK1 ϩ CD34 ϩ CXCR4 ϩ and NK1 ϩ CD34 ϩ CXCR4 ϩ cells in total mononuclear cells (0.010Ϯ0.003% versus 0.003Ϯ0.001% in controls; Pϭ0.03; nϭ10 in both groups; and 0.006Ϯ0.001% versus 0.004Ϯ0.001% in controls; Pϭ0.05; nϭ10 in both groups, respectively). The expression of CRLR was unchanged after acute myocardial infarction.
We next analyzed hearts of patients that were transplanted after acute myocardial infarction (nϭ6). Ventricular fragments obtained from 5 explanted normal hearts that were judged not to be suitable for cardiac transplantation were employed as controls. SP could be identified by immunohistochemistry particularly in the perivascular interstitium of the border zone ( Figure 8D ) and remote zone of infarcted hearts ( Figure 8E ) compared with controls ( Figure 8F ). Quantitatively, a significantly larger volume fraction of the region bordering the infarct was immunoreactive for this neurotransmitter ( Figure 8G ). We next investigated, on the same samples, the presence of NK1 ϩ cells expressing the endothelial and hematopoietic stem cell marker CD34. Moreover, CD45 was employed to label cells of clear hematopoietic origin. Both CD45 ϩ ( Figure 8H ) and CD45 Ϫ cells ( Figure 8I ) coexpressing NK1 and CD34 were identified. Quantitatively, although CD34 ϩ NK1 ϩ CD45 ϩ cell density was significantly higher in myocardium distant from the myocardial injury, CD34 ϩ NK1R ϩ CD45 Ϫ cells were significantly more frequent in the border zone compared with controls.
Finally, to verify whether denervated hearts had an impairment in the recruitment of CD34 ϩ NK1R ϩ cells in response to injury, we compared hearts of patients undergoing cardiac transplantation after an acute infarct with hearts of patients retransplanted after an infarct of the graft (nϭ3). In agreement with our hypothesis, both CD34 ϩ NK1R ϩ CD45 ϩ and CD34 ϩ NK1R ϩ CD45 Ϫ cells were less abundant in this latter class of patients ( Figure 8J ). 
Discussion
In this study, we identified the presence of primary nociceptive sensory fibers in bone marrow. We also found that bone marrow PC express NK1, the preferential receptor of SP, and migrate in response to SP stimulation. Ischemic injury remarkably increases SP levels in peripheral blood and induces the mobilization of proangiogenic PC, with these responses being abrogated by the opioid agonist morphine. Moreover, genetic disruption of the NK1 receptor in bone marrow cells results in defective PC mobilization, reduced reparative angiogenesis, and delayed postischemic recovery. NK1 receptor-expressing cells are abundant in human infarcted hearts but not in denervated hearts that suffered an infarct after transplantation. Hence, we conclude that the SP/NK1 duo is implicated in postischemic reparative response.
Primary Sensory Neurons Innervate Mouse Bone Marrow, and Bone Marrow PC Express SP and CGRP Receptors
The presence of sympathetic and sensory nerve fibers in bones and marrow of rodents has been reported previously. [22] [23] [24] This study further identifies the intramedullary distribution of peptidergic primary sensory fibers, which were recognized by costaining for SP, CGRP, and TRPV1, a marker for capsaicin-sensitive fibers implicated in neurogenic inflammation and pain 25 (Figure I in the online-only Data Supplement). Multicolor fluorescence microscopy confirmed the distribution of SP-positive fibers in bone marrow parenchyma, thus providing an anatomic basis for the existence of neurogenic control of PC homeostasis (Figure 1 ). This concept is strengthened by the other finding that bone marrow cells express neuropeptide receptors. 26 -29 Using flow cytometry, we newly document that NK1, CRLR, and RAMP-1 receptors are particularly abundant in mouse c-Kit ϩ PC (Figure 2 ) and human CD34 ϩ PC ( Figure V in the online-only Data Supplement). Both populations have been reported to participate in the postischemic regenerative process. 4, 30 Moreover, we report for the first time the ability of bone marrow cells to respond to neuropeptide stimulation in migration assays (Figures 3 and 7) as well as in vivo after intravenous administration of SP ( Figure III in the online-only Data Supplement) or change in the SP gradient between bone marrow and peripheral blood after ischemia (Figures 4 and 8) . Interestingly, PC expressing distinct neuropeptide receptors show competence to respond to both SP and CGRP, suggesting complementary/synergistic attraction by the 2 agonists. Moreover, because neuropeptide receptor-expressing cells coexpress chemokine receptors, such as CXCR4, neuroendocrine mechanisms may integrate the chemokine-mediated mechanism of PC mobilization and recruitment. 31 The 2 mechanisms share common postreceptor signaling pathways. In fact, similar to SDF-1, which is the ligand of CXCR4, SP induces Akt phosphorylation in bone marrow PC. Inhibition of phosphoinositide-3 kinase contrasts the stimulatory effects of SP on Akt phosphorylation and PC migration.
Opioid Analgesia Abrogates the Mobilization of NK1-Expressing Cells After Ischemia
Pain is a typical symptom of acute ischemia and an essential component of the alert response to injury. Moreover, it is well known that opioid receptors and the SP receptor NK1 coexist and functionally interact in somatic and visceral sensory neurons, spinal cord projection and interneurons, midbrain, and cortex. Opioid receptors and neuropeptides like SP are synthesized in the DRG and transported along intra-axonal microtubules into central and peripheral processes of the primary afferent neuron. At the terminals, opioid receptors are incorporated into the neuronal membrane and become functional receptors. Activation of mature opioid receptors by endogenous ligands or systemically administered agonists potently inhibits SP release induced by peripheral noxious stimuli through coupling to G proteins that suppress cAMPdependent Ca 2ϩ or Na ϩ currents. 32 After acute injury, nociceptors and opioid receptors may also cooperate in the fine tuning of reparative responses. It was reported previously that morphine delays wound closure, reduces the number of circulating endothelial PC, and impairs reparative angiogenesis in mice. 16 However, whether ischemic pain participates in mobilization of PC through the SP/NK1 duo has not been considered previously. We here report that acute myocardial infarction and limb ischemia increase the levels of circulating SP in mice and human patients, and this effect is associated with an augmented abundance of circulating NK1expressing PC. Importantly, morphine abrogated the SP gradient between bone marrow and peripheral blood and the mobilization of NK1 ϩ PC (Figure 4) , thus confirming the intertwined link between ischemic injury, SP signaling, and PC egress. However, further studies are warranted to address the role of pain afferents or efferents in this process.
The NK1 Receptor Is Fundamental for PC Mobilization and Reparative Response After Ischemia
Previous studies from Mishima et al 33 have shown that limb ischemia increases the expression of pro-CGRP mRNA and of CGRP protein in the lumbar DRG. In CGRP knockout mice, they observed impaired blood flow recovery from ischemia and decreased capillary density. Likewise, SP has been implicated in reparative angiogenesis, regulation of hematopoiesis, and recruitment of mesenchymal stem cells. 2, 7, 34 To dissect reparative actions that could be ascribed to either local stimulation of angiogenesis or recruitment of proangiogenic cells by SP, we studied the postischemic recovery of mice whose bone marrow had been reconstituted with NK1-KO cells. Results indicate that the lack of NK1 receptor results in impaired PC mobilization, defective angiogenesis, and delayed perfusion recovery ( Figure 5 ). There- fore, an operative NK1 receptor is required for bone marrow cells to elicit reparative responses.
The spectrum of cells released after an ischemic event is heterogeneous and comprises inflammatory and regenerative subpopulations. We used a functional enrichment method based on in vitro migration to verify whether neuropeptideresponsive cells belong to the class of regenerative cells. 20 We found that human SP mig and CGRP mig cells enhance the formation of new branches of cocultured human umbilical vein endothelial cells (Figure 7) . Moreover, mice transplanted with SP-responsive PC show increased arteriogenesis and improved blood flow recovery of the ischemic limb compared with vehicle-injected mice receiving injection of vehicle ( Figure 6 ).
Homing of NK1-Expressing Cells in Infarcted Human Hearts
We report the presence of SP and NK1 ϩ CD34 ϩ CD45 ϩ PC in the remote zone of infarcted human hearts (Figure 8 ). These cells are remarkably less abundant in posttransplant infarcted hearts, suggesting that denervation may have hampered PC recruitment. These data need to be confirmed in a larger series of transplanted hearts and in models of cardiac denervation. Moreover, we observed that NK1 ϩ CD34 ϩ CD45 Ϫ cells are more abundant in the border of infarcted human myocardium and mainly localized in vascular-like structures. It is not clear whether NK1 ϩ CD34 ϩ CD45 Ϫ cells are resident vascular cells or derive Figure 8 . Activation of substance P (SP)-based nociceptive signaling after acute myocardial infarction (aMI) is associated with mobilization and homing of neurokinin 1 (NK1)-expressing progenitor cells. A, aMI increases peripheral blood (PB) levels of SP; *PϽ0.05, aMI vs controls (nϭ23 and 19, respectively). B and C, aMI increases PB levels of PC positive for CD34/CXCR4 (B) and CD34/KDR (C) that coexpress NK1 and receptor activity-modifying protein 1 (RAMP-1) receptors. *PϽ0.05, **PϽ0.01, ***PϽ0.001 vs controls; nϭ10 per group. CRLR indicates calcitonin receptor-like receptor. D through F, Representative microscopy images of SP staining in human myocardium at the level of infarct border zone (D) and remote zone (E). Normal myocardium shows low levels of SP expression (F). G, Bar graph showing the expression of SP in hearts of aMI patients (nϭ6) and healthy controls (nϭ5). IHC indicates immunohistochemistry. H and I, Abundance of NK1-expressing cells coexpressing CD34 and CD45 (H) or CD34 only (I). Bar graphs show the abundance of NK1 ϩ CD34 ϩ CD45 ϩ cells (H) and NK1 ϩ CD34 ϩ CD45 Ϫ cells (I) in hearts of aMI patients (nϭ6) and healthy controls (nϭ5). *PϽ0.05 vs healthy, #PϽ0.05 vs border zone. J, Levels of SP and abundance of NK1 ϩ CD34 ϩ CD45 ϩ cells and NK1 ϩ CD34 ϩ CD45 Ϫ cells in hearts of transplanted (nϭ6) and retransplanted aMI patients (nϭ3). *PϽ0.05 vs transplanted.
